KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Cash from Investing Activities (2018 - 2025)

Progyny (PGNY) has disclosed Cash from Investing Activities for 8 consecutive years, with -$279.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities changed N/A to -$279.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$273.0 million, a N/A change, with the full-year FY2025 number at -$159.0 million, down 181.22% from a year prior.
  • Cash from Investing Activities was -$279.8 million for Q4 2025 at Progyny, down from -$94.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $86.1 million in Q2 2024 to a low of -$279.8 million in Q4 2025.
  • A 5-year average of -$28.8 million and a median of -$1.9 million in 2022 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 344.58% in 2021, then plummeted 7863.68% in 2023.
  • Progyny's Cash from Investing Activities stood at -$6.3 million in 2021, then skyrocketed by 81.42% to -$1.2 million in 2022, then tumbled by 7863.68% to -$93.4 million in 2023, then surged by 116.45% to $15.4 million in 2024, then tumbled by 1921.48% to -$279.8 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Cash from Investing Activities are -$279.8 million (Q4 2025), -$94.6 million (Q1 2025), and $15.4 million (Q3 2024).